Multiple Sclerosis (MS) - Relapsing-remitting
Neurology·MeSH: Multiple Sclerosis, Relapsing-Remitting
Prevalence
120.0 / 100K
Incidence
7.0 / 100K/yr
0 drugs in development·0 companies·4 clinical trials
Frequently asked questions
How many clinical trials target Multiple Sclerosis (MS) - Relapsing-remitting?
There are 4 clinical trials targeting Multiple Sclerosis (MS) - Relapsing-remitting tracked by BioSniper.
What is the prevalence of Multiple Sclerosis (MS) - Relapsing-remitting?
The estimated prevalence of Multiple Sclerosis (MS) - Relapsing-remitting is approximately 120.0 per 100,000 population.
Deep-dive into Multiple Sclerosis (MS) - Relapsing-remitting
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis